Table 1.
Gene | Oligosense 5′→3′ | Oligoantisense 5′→3′ |
---|---|---|
Cnr1 | ACCCATGGCTGAGGGTT | GGTACGGAAGGTGGTGTCTG |
Dagla | GCAGTGTCAGGAGCAAGTCT | AGCAGCAACAGCTCTACAGG |
Daglb | ACGACAAGGTGTACGAGCTG | TCCAGCTCTAGGTTCTCGCT |
Mgll | CGGAACAAGTCGGAGGTTGA | AAGCATACCTTCACCCCTGC |
Napepld | AGCTTATGAGCCAAGGTGGT | AGCTAAGGCAAAAGTCCCCC |
Faah | GTTCACCTTGGACCCTACCG | AGAAGGGAATCAGCGTGTGG |
αCaMKII | AGGATGAAGACACCAAAGTGC | GGTTCAAAGGC-TGTCATTCC |
βCaMKII | ACCTCATTTGAGCCTGA-AGC | CAGGATAGTGGTGTGGATCG |
Gad67 | TCACAAGATGATGGGTGTGCTG | GTCATACTGCTTGTCTGGCTGGA |
Gad65 | TGACGCACTGCCAAACAACTC | TGCTGCTAATCCAACCATATCCAA |
Cnr1 cannabinoid receptor type 1, Dagla/b diacylglicerol lipase a/b, Mgll monoacylglicerollipase, Napepld N-acylphosphatidylethanolamine phospholipase D, FAAH fatty acid amide hydrolase, α/βCaMKII α/β form of calcium calmodulin-dependent protein kinase type II, Gad67/65 Glutamate decarboxylase 67/65